Piedmont Capital Investments

Scout AI specializes in developing AI-driven autonomous control systems tailored for military applications. Their core product is a modular, end-to-end mission autonomy operating system, which enables a range of unmanned ground missions. This technology allows military forces to deploy attritable drones with minimal risk to human soldiers, thereby freeing them up for more complex tasks.

MetOx Technologies is a manufacturer of high-temperature superconducting (HTS) wire, utilizing YBCO to facilitate the efficient transmission of electricity. This technology allows for the transmission of large amounts of electricity with minimal cross-sectional area, eliminating electrical loss and heat generation during operation. MetOx employs a proprietary one-pass metal-organic chemical vapor deposition process for the production of buffer and superconductor layers, enhancing the quality and cost-effectiveness of its HTS wire. The applications of this advanced wire include upgrading transmission and distribution lines, supporting magnetic confinement fusion reactors, and developing next-generation MRI scanners, as well as use in wind turbines.

Nzero is a carbon emissions tracking management platform established in 2017 and based in Carson City, Nevada. The platform operates continuously to capture and manage Scope 1, 2, and 3 emissions data with high accuracy. By utilizing customers' energy, water, and utility data alongside publicly-reported emissions and partner data, Nzero provides precise, actionable, and auditable insights. This enables organizations to take effective measures toward reducing their carbon footprint and achieving net-zero emissions. The platform also supports financial reporting, contract administration, decision-making, payments, and workflows through a user-friendly interface, helping companies meet their sustainability objectives and comply with regulatory requirements.

Pryon Inc. is an artificial intelligence company based in Raleigh, North Carolina, that focuses on enhancing enterprise knowledge management. Founded in 2017 by Igor Jablokov, Pryon develops an augmented intelligence platform that combines human and machine capabilities to streamline access to information across various channels and sources. The platform employs natural language processing and automated machine learning to transform unstructured data into actionable insights, thereby boosting productivity and decision-making accuracy. By utilizing a no-code approach, Pryon enables organizations to quickly harness the value of their information assets without disrupting existing operations. The company's solutions aim to simplify AI adoption, reduce complexity, and lower costs for businesses seeking to improve their workflows and knowledge utilization.

Tavros Therapeutics is a biotechnology company founded in 2019 and based in Durham, North Carolina. The company focuses on discovering and developing therapies for cancer, aiming to improve oncological treatment outcomes. Tavros Therapeutics is dedicated to identifying vulnerabilities within tumors, which allows for the targeted application of specific drugs in conjunction with optimal combinations. This approach is intended to enhance the effectiveness of cancer treatments and increase the potential for patient cures.

Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.

Posh is a conversational AI and NLP technology development company that enables developers to deliver a new way to interact with users. With Posh, website actions that takes minutes to complete can be sped up to just seconds with a simple message from bots. Companies in finanical services, healthcare, utilities, and beyond are using the Posh platform to re-create call centers and automate routine requests for both customers and staff while saving time and money. The company wants to make the internet experience easier and more enjoyable. Posh was launched on 2015 and is based in Boston, Massachusetts.

Immunai Inc. is a biotechnology company that specializes in developing an artificial intelligence-based immune profiling platform aimed at enhancing drug development and improving disease detection, diagnosis, and treatment. The company utilizes single-cell genomics and machine learning algorithms to conduct high-resolution profiling of the immune system, generating valuable biological insights that facilitate research and development. Immunai's platform focuses on biomarker discovery, enabling the identification of how immune cells respond to various conditions, and supports the development of therapies for oncology and autoimmune disorders. Established in 2018 and headquartered in New York City, Immunai also maintains offices in San Francisco and Tel Aviv, collaborating with academic institutions, biopharmaceutical firms, and biotechnology companies to advance its mission of mapping the immune system and its functions.

Tvardi Therapeutics, Inc. is a biotechnology company based in Houston, Texas, focused on developing innovative medicines for cancer, chronic inflammation, and fibrosis. Founded in 2017, the company specializes in small molecule inhibitors targeting STAT3, a regulatory protein involved in the progression of various cancers and fibrotic diseases. Tvardi's pipeline includes TTI-101, an oral small-molecule STAT3 inhibitor, and an intravenous formulation for non-cancer indications, as well as TTI-102, another oral candidate with potential in STAT3 inhibition. By addressing the underlying mechanisms of disease, Tvardi Therapeutics aims to provide effective treatments for patients suffering from diverse conditions, including breast and lung cancer, as well as chronic inflammatory and fibrotic diseases.

Epirus, Inc. is a technology company based in Hawthorne, California, specializing in the design and development of advanced defense systems that utilize artificial intelligence and directed energy. Founded in 2018, the company focuses on creating solid-state, software-defined high-power microwave solutions aimed at countering unmanned aircraft systems and other asymmetric threats. Its flagship product, ELECTROMAGNETIC PULSE, serves as a counter-infrastructure solution that can simultaneously target multiple threats, effectively neutralizing drones and swarms. By integrating AI and machine learning with advanced electronics, Epirus enhances the detection and tracking of objects of interest, offering innovative capabilities in electronic warfare and power management for both defense and commercial sectors.

Tavros Therapeutics is a biotechnology company founded in 2019 and based in Durham, North Carolina. The company focuses on discovering and developing therapies for cancer, aiming to improve oncological treatment outcomes. Tavros Therapeutics is dedicated to identifying vulnerabilities within tumors, which allows for the targeted application of specific drugs in conjunction with optimal combinations. This approach is intended to enhance the effectiveness of cancer treatments and increase the potential for patient cures.

Sift Media, Inc. is a company based in Durham, North Carolina, that specializes in developing automated bidding software for mobile advertisement opportunities within real-time auction exchanges. Founded in 2015, Sift Media utilizes advanced artificial intelligence and machine learning algorithms to optimize the performance of app install advertisements. The platform processes over 50 billion mobile ad requests daily, enabling clients to hyper-target their advertising efforts effectively. To date, Sift Media has served more than 40 billion mobile ads and has successfully delivered over 25 million app installs for thousands of advertisers. The company's technology supports features such as whitelisting and blacklisting of specific app bundles, allowing for tailored advertising strategies. Sift Media received $3.25 million in funding in early 2016 to further enhance its capabilities in the mobile advertising landscape.